irasia.com - Investor Relations Asia Pacific
HOME

Dawnrays Pharmaceutical (Holdings) Limited

Announcements & Notices       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2023-August-27
  • INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2023 AND CLOSURE OF REGISTER OF MEMBERS (in PDF)
  • 2023-August-25
  • ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023 (in PDF)
  • 2023-August-14
  • DATE OF BOARD MEETING (in PDF)
  • 2023-June-2
  • VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION HAS ACCEPTED THE NEW DRUG APPLICATION FOR EBRONUCIMAB INJECTION (ANTI-PCSK9 MONOCLONAL ANTIBODY, AK102) DEVELOPED BY AD PHARMACEUTICALS (in PDF)
  • 2023-May-25
  • POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 MAY 2023 (in PDF)
  • 2023-April-25
  • NOTICE OF ANNUAL GENERAL MEETING (in PDF)
  • 2023-March-26
  • FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022 AND CLOSURE OF REGISTER OF MEMBERS (in PDF)
  • 2023-March-26
  • ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022 (in PDF)
  • 2023-March-10
  • DATE OF BOARD MEETING (in PDF)
  • 2023-February-28
  • Terms of Reference of Remuneration Committee (in PDF)
  • 2023-February-28
  • Terms of Reference of Audit Committee (in PDF)
  • 2024
  • 2024 Announcements & Notices
  • 2022
  • 2022 Announcements & Notices
  • 2021
  • 2021 Announcements & Notices
  • 2020
  • 2020 Announcements & Notices
  • 2019
  • 2019 Announcements & Notices
  • 2018
  • 2018 Announcements & Notices
  • 2017
  • 2017 Announcements & Notices


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2024 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.
    Cookie Policy

    This website uses cookies. Please refer to our Cookie Notice and Privacy Notice for further information. By continuing to use this website, you agree to our use of cookies.

    Close